Molecular Partners AG (MOLN)
NASDAQ·Healthcare·Biotechnology
$3.70
+3.06%
Mkt Cap $183.26M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$21.00
Range $13.00 – $29.00
Implied Upside
+467.6%
Consensus $21.00 vs current $3.70
NASDAQ·Healthcare·Biotechnology
$3.70
+3.06%
Mkt Cap $183.26M
No recent rating data.
Price Target (2 analysts)
$21.00
Range $13.00 – $29.00
+467.6%
Consensus $21.00 vs current $3.70